PELOSI, GIUSEPPE
PELOSI, GIUSEPPE
Dipartimento di Oncologia ed Emato-Oncologia
Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
2026 M. O'Callaghan, S.H. Forde, A.N. Franciosi, M. Penugonda, R. Diesler, H. O'Brien, W. Buikhuisen, H. Almeamar, B.F. Samhouri, J.H. Ryu, M. Veltkamp, E.D. Manali, A. Lazaratou, S.A. Papiris, F. Bonella, L. Carr, V. Cottin, C. Taille, F.X. Mccormack, N. Gupta, J. Strosberg, F.M. Lococo, S. Harari, G. Pelosi, R. Papa, D. Bouros, L. Kolilekas, Z. Daniil, I. Dimeas, F. Hernandez-Gonzalez, J. Sellares, P. Spagnolo, R.K. Crowley, D. O' Toole, D. O'Shea, S. Quinn, D.J. Murphy, A. Fabre, A.J. Byrne, M.P. Keane, L. Fournel, C. Mccarthy
Revisiting rhinoscleroma microbiology: a case with concordant dual-specimen bacterial isolation
2026 L. Drago, N. Papanikolau, A. Preti, F. Mozzanica, L.R. De La Motte, G. Pelosi, L. Deflorio
IASLC Update on Classification of Pulmonary Neuroendocrine Neoplasms
2026 M.B. Beasley, Y. Yatabe, M. Papotti, W.A. Cooper, J.L. Derks, L. Fernandez-Cuesta, A. Kasajima, S. Lantuejoul, G. Pelosi, N. Rekhtman, A.C. Roden, E.J.M. Speel, W.D. Travis
Pathology, molecular biology, medical oncology, and radiotherapy implications of lung neuroendocrine neoplasm classification: a multidisciplinary perspective
2026 G. Pelosi, A. Laffi, G. Catalano, A. Bruno, M. Papotti, B. Bassani, F. Bianchi, E. Duregon, T. Martino De Pas, C. Catania, R. Ricotta, R. Papa, S. Harari, A. Sonzogni, I. Guerriero, C. Ambrosino, K. Pane, M. Franzese, M. Gemelli
Transcriptional evidence of neuroendocrine cell plasticity beyond histological boundaries in lung neuroendocrine neoplasms: an in-silico analysis suggesting a progression model
2026 G. Pelosi, M. Papotti, R. Papa, E. Duregon, M. Gemelli, S. Harari, A. Sonzogni, A. Laffi, T. De Pas, C. Catania, B. Bassani, F. Lotti, A. Bruno, P. Muti, F. Bianchi
Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids
2026 A. Sexton-Oates, É. Mathian, N. Candeli, Y. Lim, C. Voegele, A. Di Genova, L. Mangé, Z. Li, T. Van Weert, L. Kalson, T.M. Delhomme, L.M. Hillen, R. Blázquez-Encinas, A. Gonzalez-Perez, M.L. Morrison, E. Lauricella, L. Mangiante, L. Bonheme, L. Moonen, G. Absenger, J. Altmuller, C. Degletagne, O.T. Brustugun, V. Cahais, G. Centonze, A. Chabrier, C. Cuenin, F. Damiola, V.T. De Montpréville, J. Deleuze, A.C. Dingemans, É. Fadel, N. Gadot, A. Ghantous, P. Graziano, P. Hofman, V. Hofman, A. Ibáñez-Costa, S. Lacomme, N. Lopez-Bigas, M. Lund-Iversen, M. Milione, L.A. Muscarella, S. Pedraza-Arevalo, C. Perrin, G. Planchard, H. Popper, L. Roz, A. Sparaneo, W. Buikhuisen, J. Van Den Berg, M. Tesselaar, J. Kim, E.J.M. Speel, S. Tabone-Eglinger, T. Walter, G.M. Wright, J.P. Castaño, L. Chalabreysse, L. Chen, C. Caux, M. Volante, N. Girard, J. Vignaud, E. Conde, A. Mansuet-Lupo, L. Brcic, G. Pelosi, M.G. Papotti, S. Lantuejoul, J. Derks, T. Dayton, N. Alcala, M. Foll, L. Fernandez-Cuesta
Targeted therapies in thoracic neuroendocrine tumors: challenges and failures of tyrosine kinase inhibition in lung and thymic carcinoids
2026 A. Laffi, C. Catania, M. De Pas, A. Lania, E. Vitali, R. Papa, G. Pelosi
MesoRet: a reticulin stain-based deep learning algorithm to assist diffuse mesothelioma subtyping
2026 G. Orlando, A.P. Ferrero, G.A. Impalà, A. Pittaro, L. Delsedime, R. Pedrosa, D. Kumar, L. Righi, G. Pelosi, M.G. Papotti, E. Duregon
Stromal-only endometriosis catamenial pneumothorax: A diagnostic algorithm with potential pitfalls
2026 R. Papa, A. Meroni, M. Incarbone, G. Pelosi
Three-tier prognostic stratification of lung carcinoids (NET G1-G2-G3) by multivariable, data-driven integration of Ki-67 and mitotic count
2026 G. Orlando, V. Veronesi, E. Duregon, V. Zambelli, F. Leo, E.C. Fontana, E. Ruffini, L. Righi, G. Pelosi, M. Volante, M. Papotti
TERT Expression and Clinical Outcome in Pulmonary Carcinoids
2025 L. Werr, C. Bartenhagen, C. Rosswog, M. Cartolano, C. Voegele, A. Sexton-Oates, A. Di Genova, A. Ernst, Y. Kahlert, N. Hemstedt, S. Höppner, A. Mansuet Lupo, G. Pelosi, L. Brcic, M. Papotti, J. George, G. Bosco, A. Quaas, L.H. Tang, K. Robzyk, K. Kadota, M.S. Roh, R.E. Fanaroff, C.J. Falcon, R. Büttner, S. Lantuejoul, N. Rekhtman, C.M. Rudin, W.D. Travis, N. Alcala, L. Fernandez-Cuesta, M. Foll, M. Peifer, R.K. Thomas, M. Fischer, N. Null, G. Absenger, J. Altmüller, J. Berthet, F. Bibeau, C.B. Fourner, A. Boland, C. Bonnetaud, M. Brevet, O.T. Brustugun, G. Centonze, L. Chalabreysse, C. Cohen, J. Deleuze, J.L. Derks, C.M. Di Micco, A.C. Dingemans, É. Fadel, P. Graziano, P. Hofman, V. Hofman, S. Lacomme, M. Lund-Iversen, J. Metovic, M. Milione, L. Moonen, L.A. Muscarella, P. Nürnberg, R. Olaso, V. Meyer, C. Perrin, G. Planchard, H. Popper, N. Rousseau, L. Roz, G. Sabella, A. Sparaneo, E.J.M. Speel, F. Thivolet-Béjui, V. Thomas de Montpréville, M. Volante, G.M. Wright, F. Damiola, S. Tabone-Eglinger, N. Girard
Current approaches, barriers, and future directions in pleural mesothelioma diagnostics: results from an Italian National Survey
2025 F. Pezzuto, G. Lopez, F. Barbisan, L. Rosso, G. Pelosi, M. Papotti, L. Righi, F. Calabrese
Modeling large cell neuroendocrine carcinoma of the lung for molecular, therapeutic and microenvironmental inferences: current knowledge and future perspectives
2025 G. Pelosi, M. Gemelli, F. Bianchi, M. Papotti, E. Duregon, R. Ricotta, R. Papa, S. Harari, A. Sonzogni, A. Laffi, B. Bassani, A. Bruno
Lung Carcinoids in Adolescents and Young Adults (AYAs): A Still Overlooked Clinical Entity
2025 A. Laffi, L. Pala, C. Catania, M. Locatelli, P. Cascetta, E. Cocorocchio, G.L. Ceresoli, D. Laszlo, F. Facella, E. Governini, M. Bendoni, G. Pelosi, F. Conforti, T.M. De Pas
Clinical needs and pathology’s answers in neuroendocrine neoplasms of the lung
2025 G. Pelosi, A. Laffi, M. Papotti, S. Lantuejoul, J. Scoazec, M. Gemelli, R. Ricotta, S. Harari, E. Duregon, R. Papa, A. Sonzogni, F. Bianchi, A. Bruno, B. Bassani, S. Uccella, C. Carnaghi, A. Bertuzzi
A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkers
2025 E. Thunnissen, H. Blaauwgeers, F. Filipello, B. Lissenberg-Witte, Y. Minami, M. Noguchi, J.L. Quesne, M.G. Papotti, D.B. Flieder, G. Pelosi, I. Sansano, S. Berezowska, A. Ryška, L. Brcic, N. Motoi, Y. Nakatani, C. Kuempers, P. Hofman, V. Hofman, V.G. Dale, G. Rossi, F. Ambrosi, D. Matsubara, Y. Ishikawa, B. Weynand, F. Calabrese, F. Pezzuto, I. Kern, S. Nicholson, A. Mutka, S. Dacic, M.B. Beasley, G. Arrigoni, W. Timens, M. Ooft, M. Brinkhuis, N. Bulkmans, R. Britstra, W. Vreuls, K.D. Jones, J.H. von der Thüsen, H. Hager, S. Perner, D. Moore, D.G. Leonte, S. Al-Janabi, A. Schønau, O. Neumann, K. Kluck, I. Ourailidis, M. Ball, J. Budczies, D. Kazdal, A. Stenzinger
A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a STRN-ALK fusion by artificial intelligence and molecular modelling: a case report
2024 M. Barberis, A. Rappa, F. De Marinis, G. Pelosi, E.G. Rocco, Y. Zhan, G. Tiana
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms
2024 G. Pelosi, V. Melocchi, E. Dama, P. Hofman, M. De Luca, A. Albini, M. Gemelli, R. Ricotta, M. Papotti, S. La Rosa, S. Uccella, S. Harari, A. Sonzogni, M.K. Asiedu, D.A. Wigle, F. Bianchi
Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature
2024 A. Marando, M. Zagni, M. Negrelli, E. Valtorta, C. Lauricella, V. Motta, S. Veronese, G. Cerea, L.G. Giannetta, G. Ciarlo, D. Signorelli, E.G. Pizzutilo, E. Bonoldi, G. Pelosi
Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study
2024 S. Harari, D. Elia, A. Caminati, J. Geginat, F. Luisi, G. Pelosi, C. Specchia, O. Torre, R. Trevisan, C. Vasco, M. Zompatori, R. Cassandro